NCT03824132View on ClinicalTrials.gov

LOL: It's All Improv After Cancer!™

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 2, 2019

Primary Completion Date

July 19, 2024

Study Completion Date

July 19, 2024

Conditions
Breast CancerPsychological Distress
Interventions
BEHAVIORAL

Improvisational comedy classes

6 consecutive improvisational comedy classes

BEHAVIORAL

Waitlist control

After 10 week waitlist control, subjects will complete 6 consecutive improvisational comedy classes.

Trial Locations (1)

90048

Cancer Clinical Trials Office, Los Angeles

All Listed Sponsors
collaborator

Tower Cancer Research Foundation

UNKNOWN

lead

Arash Asher, MD

OTHER

NCT03824132 - LOL: It's All Improv After Cancer!™ | Biotech Hunter | Biotech Hunter